Marlies Sproll
Chief Scientific Officer
Regulatory Affairs
MorphoSys
Germany
Biography
Sproll joined MorphoSys as R&D department head in 2000. In 2005, she was promoted to Chief Scientific Officer. Her current areas of responsibility include technology development, discovery, manufacturing, alliance management and intellectual property. Before joining MorphoSys AG, Dr. Sproll held various R&D positions in the pharmaceutical industry, e.g. at the Vienna research facility of Boehringer Ingelheim and at E. Merck KGaA in Darmstadt, Germany, focusing on the discovery and development of antibody-based drugs and cancer vaccines. Dr. Sproll studied Biology and was awarded a Doctor of Natural Sciences by the Technical University of Stuttgart, Germany. Before joining the industry, she held various research positions at different institutes of the Max-Planck Society in Tübingen, Germany.
Research Interest
Natural Sciences